# ![@shindaejin0722 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1503582035046440961.png) @shindaejin0722 hyperdean

hyperdean posts on X about $deft, $srpt, $defts, in the the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::1503582035046440961/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1503582035046440961/c:line/m:interactions.svg)

- [--] Week [-----] -23%
- [--] Month [------] -60%
- [--] Months [-------] +33%
- [--] Year [-------] +3,877%

### Mentions: [--] [#](/creator/twitter::1503582035046440961/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1503582035046440961/c:line/m:posts_active.svg)

- [--] Week [--] -16%
- [--] Month [---] -28%
- [--] Months [---] +77%
- [--] Year [---] +3,136%

### Followers: [---] [#](/creator/twitter::1503582035046440961/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1503582035046440961/c:line/m:followers.svg)

- [--] Week [---] -0.31%
- [--] Month [---] no change
- [--] Months [---] +15%
- [--] Year [---] +103%

### CreatorRank: [---------] [#](/creator/twitter::1503582035046440961/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1503582035046440961/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  79.49% [finance](/list/finance)  23.93% [cryptocurrencies](/list/cryptocurrencies)  8.55% [travel destinations](/list/travel-destinations)  2.56% [countries](/list/countries)  2.56% [exchanges](/list/exchanges)  2.56% [financial services](/list/financial-services)  1.71%

**Social topic influence**
[$deft](/topic/$deft) #2, [$srpt](/topic/$srpt) 34.19%, [$defts](/topic/$defts) #1, [in the](/topic/in-the) 8.55%, [$srpts](/topic/$srpts) #1, [rwa](/topic/rwa) 5.98%, [$btc](/topic/$btc) 5.98%, [products](/topic/products) 5.13%, [cryptocurrency](/topic/cryptocurrency) #2874, [strong](/topic/strong) 5.13%

**Top accounts mentioned or mentioned by**
[@cschlauf](/creator/undefined) [@jhnwtt](/creator/undefined) [@forson](/creator/undefined) [@defitechglobal](/creator/undefined) [@reyni985](/creator/undefined) [@eugenjen54441](/creator/undefined) [@douglasingram](/creator/undefined) [@olivierfrancois](/creator/undefined) [@missjanesmike](/creator/undefined) [@valourfunds](/creator/undefined) [@resourcemav](/creator/undefined) [@fattyfatty12352](/creator/undefined) [@russnstarr](/creator/undefined) [@yachmod](/creator/undefined) [@renegrnr](/creator/undefined) [@cherl57](/creator/undefined) [@anthonynoto](/creator/undefined) [@sofi](/creator/undefined) [@jbuchanan28](/creator/undefined) [@deepvaueadv](/creator/undefined)

**Top assets mentioned**
[Defi Technologies, Inc. (DEFT)](/topic/$deft) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Bitcoin (BTC)](/topic/$btc) [Pagaya Technologies Ltd. Class A Ordinary Shares (PGY)](/topic/$pgy) [Ethereum (ETH)](/topic/$eth) [Agilon Health, Inc. (AGL)](/topic/$agl) [Born in [--] (19)](/topic/$19) [BlackRock Inc (BLK)](/topic/blackrock) [RAI Finance (SOFI)](/topic/$sofi) [Upstart Holdings, Inc. (UPST)](/topic/$upst) [Layerzero (ZRO)](/topic/layerzero)
### Top Social Posts
Top posts by engagements in the last [--] hours

"@anthonynoto @SoFi Since [------] when $SoFi was around $20 I have been with $SoFi. I made accounts for my wife and children and started collecting $SoFi stocks. Because I believe $SoFi and @anthonynoto will be good at fintech. Now we have more than [-----] shares"  
[X Link](https://x.com/shindaejin0722/status/1689734223379542016)  2023-08-10T20:23Z [---] followers, [---] engagements


"$PGY Wedbush Raises Earnings Estimates for Pagaya Technologies https://www.marketbeat.com/instant-alerts/q4-eps-estimates-for-pagaya-technologies-raised-by-wedbush-2024-11-27/ https://www.marketbeat.com/instant-alerts/q4-eps-estimates-for-pagaya-technologies-raised-by-wedbush-2024-11-27/"  
[X Link](https://x.com/shindaejin0722/status/1861926756153987083)  2024-11-28T00:15Z [---] followers, [---] engagements


"$PGY is finished at 10.28% today. Don't disappoint what's changing is nothing. Pagaya still go upside. I'm expecting $30 in shar term and $60 in long term. Do you join us"  
[X Link](https://x.com/shindaejin0722/status/1891963601327428011)  2025-02-18T21:30Z [---] followers, [----] engagements


"$PGY The movement of the Pre-market stock price appears to be an artificial manipulation by short sellers to recover their losses. Or is there a reason for it to go this low"  
[X Link](https://x.com/shindaejin0722/status/1892541220792193247)  2025-02-20T11:46Z [---] followers, [---] engagements


"$PGY Artificial manipulation of a stock's price can lead to bigger losses and bigger short squeezes"  
[X Link](https://x.com/shindaejin0722/status/1892545646608965849)  2025-02-20T12:03Z [---] followers, [---] engagements


"$PGY I believe it needs to be at least at the same level as its peer $UPST before I can decide whether to hold or sell. The institution that issued the short report was too hasty"  
[X Link](https://x.com/shindaejin0722/status/1892880887953707323)  2025-02-21T10:15Z [---] followers, [---] engagements


"8/8 $SRPT's bounceback could start overseas not in the U.S. From Tokyo to London to Brussels ELEVIDYS is quietly rebooting. The death paused progress it didnt end the story. Recovery is underway"  
[X Link](https://x.com/shindaejin0722/status/1932203954542383307)  2025-06-09T22:31Z [---] followers, [---] engagements


"1/8 $SRPT plunged 50% after Q1 earnings citing a projected 20% drop in Q2 revenue due to a fatality tied to ELEVIDYS. But recent global developments suggest that drop may be far smaller than expected. Heres why. 👇"  
[X Link](https://x.com/shindaejin0722/status/1932204445796045294)  2025-06-09T22:33Z [---] followers, [---] engagements


"6 Expected Returns: Short-term (6-12 months) EMA hold lift and MAA approval could drive $SRPT to $60-$80 (50-100% return). Long-term (2-3 years) LGMD approvals and global expansion may push it to $100-$120 (150-200% return)"  
[X Link](https://x.com/shindaejin0722/status/1932717716806513107)  2025-06-11T08:33Z [---] followers, [---] engagements


"Elevidys EMA Update 🧬 🔹 EMA paused EU trials due to a patient death. 🔹 Independent DMC supports trial continuation. 🔹 Sarepta expects minimal impact on timelines. 🔹 EU approval likely by late 2025Q1 [----]. 🔹 Analysts see 60% approval odds. $SRPT"  
[X Link](https://x.com/shindaejin0722/status/1933279403183911234)  2025-06-12T21:45Z [---] followers, [---] engagements


"I believe the recent $SRPT Elevidys incident may have a different impact than the previous one. Most investors who stayed since [----] are likely to hold not panic sell. Only a portion of recent entrants might exit with small losses. $SRPT"  
[X Link](https://x.com/shindaejin0722/status/1934379773301866817)  2025-06-15T22:37Z [---] followers, [----] engagements


"Does the non-ambulatory segment of $SRPT Elevidys really account for over 30% of the companys value It represents less than 10% of sales and is likely already priced in. Focus on the real value Elevidys for ambulatory patients. $SRPT"  
[X Link](https://x.com/shindaejin0722/status/1934549656798920921)  2025-06-16T09:52Z [---] followers, [----] engagements


"$SRPT will likely clear the non-ambulatory Elevidys issue by late [----] as safety protocols improve and trial data matures. Meanwhile multiple pipeline assets are set to achieve key regulatory milestones. Once the overhang lifts the market reprice back to fair value($80/share)"  
[X Link](https://x.com/shindaejin0722/status/1934745453029150961)  2025-06-16T22:50Z [---] followers, [---] engagements


"Everyones chasing dreams in biotechstartups with no products no sales just promises. Yet they say $SRPT is "worthless" $SRPT has FDA approvals growing revenue and a pipeline thats just getting started. You dont have to be. Undervalued. Underestimated. Unmissable"  
[X Link](https://x.com/shindaejin0722/status/1934912548752773282)  2025-06-17T09:54Z [---] followers, [----] engagements


"Today is the last day of the first half of [----]. I am hopeful that today will be the last day of the $SRPT stock price decline and transition to the upside"  
[X Link](https://x.com/shindaejin0722/status/1939442236988788941)  2025-06-29T21:53Z [---] followers, [---] engagements


"Duchenne Muscular Dystrophy (DMD) causes progressive muscle damage. No cure existsonly treatments that slow the damage. In the U.S. over one child is diagnosed every day. For ambulatory patients $SRPT #Elevidys is the only FDA fully approved gene therapy"  
[X Link](https://x.com/shindaejin0722/status/1942330992351666509)  2025-07-07T21:12Z [---] followers, [---] engagements


"Many ambulatory patients are waiting to receive $SRPTs #Elevidys. Non-ambulatory patients hope for FDA reapproval with enhanced safety protocols. All of them are heroes bravely fighting DMD every day"  
[X Link](https://x.com/shindaejin0722/status/1942333969590280457)  2025-07-07T21:24Z [---] followers, [---] engagements


"$SRPT 2/ ✅ PMO platform (Phosphorodiamidate Morpholino Oligomers): SRPT holds the only clinically validated PMO platform in DMD. With proven delivery efficiency and high exon-skipping precision PMO is a cornerstone tech undervalued by the market"  
[X Link](https://x.com/shindaejin0722/status/1944181913356312929)  2025-07-12T23:47Z [---] followers, [---] engagements


"$SRPT https://www.instagram.com/reel/DMGIdBrOW0h/igsh=MWF4cHRuaG84MTFxZA== https://www.instagram.com/reel/DMGIdBrOW0h/igsh=MWF4cHRuaG84MTFxZA=="  
[X Link](https://x.com/shindaejin0722/status/1944849684742427085)  2025-07-14T20:01Z [---] followers, [----] engagements


"$SRPT As of Q1 [----] [---] patients have received Elevidys with a reported mortality rate of just 0.22% (2 non-ambulatory cases). By the end of Q2 [----] total treated patients are projected to exceed [----] and the overall mortality rate is expected to drop to 0.17%"  
[X Link](https://x.com/shindaejin0722/status/1945084061774688633)  2025-07-15T11:32Z [---] followers, [---] engagements


"Is there bad news for $DEFT The stock is very low and earnings are above expectations. The business environment couldn't be better. I expect $5+ this year and $35 in the not-too-distant future"  
[X Link](https://x.com/shindaejin0722/status/1955757770944471109)  2025-08-13T22:26Z [---] followers, [----] engagements


"1. in each country there are people who want to invest in cryptocurrencies through ETFs and ETPs. [--]. it is more stable to find demand in new markets than to increase the percentage of this demand. [--]. For this reason $DEFT is increasing the number of launch countries"  
[X Link](https://x.com/shindaejin0722/status/1956206998162432184)  2025-08-15T04:11Z [---] followers, [---] engagements


"@jbuchanan28 The problem I see with $DEFT is that it isn't attracting market attention. Its price range is too low for institutions to enter and frankly the stakes held by key executives are also too small. If someone were to get just a little greedy they could easily become the largest"  
[X Link](https://x.com/shindaejin0722/status/2010856101231862003)  2026-01-12T23:27Z [---] followers, [---] engagements


"@DeFiTechGlobal @jhnwtt @Forson @CSchlauf Here are our recommendations for the $DEFT strategy: [--]. Continuously share net capital inflows. [--]. Focus more on institutional marketing during unfavorable market conditions. [--]. Develop flexible strategies considering trends like RWA and stablecoins"  
[X Link](https://x.com/shindaejin0722/status/2014843592226046326)  2026-01-23T23:32Z [---] followers, [---] engagements


"@CSchlauf Several shareholders have requested $DEFT's entry into the U.S. market. $DEFT has stated it remains focused on regions outside the U.S. How about persuading them of the value of this regional focus strategy and continuing to share our achievements"  
[X Link](https://x.com/shindaejin0722/status/2015273247701651858)  2026-01-25T03:59Z [---] followers, [---] engagements


"Following its Q3 [----] earnings release institutions set a target price of $3.50 for $DEFT. Since then it has entered the Brazilian market and today began selling $BTC and $ETH ETP products in the UK that generate staking income"  
[X Link](https://x.com/shindaejin0722/status/2015851223862354068)  2026-01-26T18:15Z [---] followers, [---] engagements


"Why shouldn't you invest in $DEFT which operates with a non-borrowed surplus continuously expands its market launches staking $BTC and $ETH ETPs & has funds poised for further growth While the low price is painful for existing shareholders it's an attractive tip for new one"  
[X Link](https://x.com/shindaejin0722/status/2015887695026045282)  2026-01-26T20:40Z [---] followers, [---] engagements


"@CSchlauf [--]. What is $DEFT focusing on these days [--]. Can $DEFT generate profits especially during a bear market [--]. Is the strategy being prepared defensive or aggressive [--]. Do you think $DEFT's stock price is low What do you consider the internal factors to be"  
[X Link](https://x.com/shindaejin0722/status/2017351800987521334)  2026-01-30T21:38Z [---] followers, [---] engagements


"@DeepVaue_Adv Cash holdings for Q3 [----] totaled $119.5M with digital asset holdings at $46.2M. $DEFT recorded a net profit of $3.9M for Q3 & a cumulative net profit of $33.8M. Even considering the four months since September [----] current cash reserves are estimated at approximately $90110M"  
[X Link](https://x.com/shindaejin0722/status/2017409327108395429)  2026-01-31T01:27Z [---] followers, [---] engagements


"@CSchlauf @wombat_oz_14 @olivierfrancois I am struggling more than anyone else with the falling stock price but I am grateful for your shared belief that good results will follow. At this very moment I hope our debt-free management profitable operations and improved financial position will shine through. $DEFT"  
[X Link](https://x.com/shindaejin0722/status/2017927387477139800)  2026-02-01T11:45Z [---] followers, [---] engagements


"The asset value of cryptocurrencies has significantly decreased. At this critical juncture the management strategy of $DEFT which has secured over $100 million in liquidity has become paramount"  
[X Link](https://x.com/shindaejin0722/status/2018867838900146294)  2026-02-04T02:02Z [---] followers, [---] engagements


"$DEFT has adopted a pragmatic strategy over a popular one. Do not rely solely on @CSchlauf. @jhnwtt must also step up and consistently communicate proactively about the company's value and strategy. In a crisis situation the CEO's continuous communication is paramount"  
[X Link](https://x.com/shindaejin0722/status/2016605566421127267)  2026-01-28T20:13Z [---] followers, [---] engagements


"$DEFT is recruiting personnel to expand into the Swedish market. https://www.linkedin.com/posts/johwat_institutional-sales-stockholm-etps-och-activity-7421539018561179648-WT4autm_source=share&utm_medium=member_android&rcm=ACoAAANYy3IB0OrBDgHHWRTVoqy0EuXd9emEo3g https://www.linkedin.com/posts/johwat_institutional-sales-stockholm-etps-och-activity-7421539018561179648-WT4autm_source=share&utm_medium=member_android&rcm=ACoAAANYy3IB0OrBDgHHWRTVoqy0EuXd9emEo3g"  
[X Link](https://x.com/shindaejin0722/status/2016629661128929605)  2026-01-28T21:49Z [---] followers, [---] engagements


"The majority of $DEFT shareholders seem to have given up and left $DEFT this week feeling very angry. They may have been wise but I still believe it can go up to $3 to $15. The current management is not repeating the mistakes of the past. $DEFT"  
[X Link](https://x.com/shindaejin0722/status/2017376680831332466)  2026-01-30T23:17Z [---] followers, [----] engagements


"Due to the current downturn in the crypto market total AUM are decreasing and consequently $DEFT's revenue is also expected to decline. However the key point is that the funds raised by $DEFT will amplify its influence in the current environment according to its strategy"  
[X Link](https://x.com/shindaejin0722/status/2017379276287512664)  2026-01-30T23:27Z [---] followers, [---] engagements


"May God's blessings be with those who purchase $DEFT now. And divine blessings will also be with those who hold $DEFT"  
[X Link](https://x.com/shindaejin0722/status/2018336434558820639)  2026-02-02T14:51Z [---] followers, [----] engagements


"@Reyni985 @MissJanesMike On top of that with $100 million in funding secured the potential for growth is extremely high depending on the strategy. $DEFT"  
[X Link](https://x.com/shindaejin0722/status/2018438855184265423)  2026-02-02T21:38Z [---] followers, [---] engagements


"Stablecoins and real-world assets (RWA) signify a transition to a more efficient system than the one currently in use. This represents the most significant transformation since the shift from paper documents to digital documents and it is a concept distinct from $BTC. $DEFT"  
[X Link](https://x.com/shindaejin0722/status/2020467222674596105)  2026-02-08T11:58Z [---] followers, [---] engagements


"Once this cryptocurrency bear market ends another 2-3 years of growth will follow. During this period $DEFT will internalize external custody services to enhance returns and transform into a global cryptocurrency asset manager"  
[X Link](https://x.com/shindaejin0722/status/2019779189344174471)  2026-02-06T14:24Z [---] followers, [---] engagements


"RT @CathieDWood: After getting to know the LayerZero team and what theyve been building over the past year I couldnt think of a better o"  
[X Link](https://x.com/shindaejin0722/status/2021358300122710373)  2026-02-10T22:59Z [---] followers, [---] engagements


"RT @MELORICH_KOREA: 🚨 :        . RWA  📷 *RWA"  
[X Link](https://x.com/shindaejin0722/status/2021566596024881360)  2026-02-11T12:46Z [---] followers, [--] engagements


"RT @Forson: I am super proud of the team of Data Analysts Quantitative Engineers and technologists @ValourFunds and @DeFiTechGlobal for t"  
[X Link](https://x.com/shindaejin0722/status/2021796526868378007)  2026-02-12T04:00Z [---] followers, [--] engagements


"If the RWA market becomes active $DEFT could operate various ETP products composed of RWAs right If my thinking is correct AUM could have increased significantly. Please share your thoughts"  
[X Link](https://x.com/shindaejin0722/status/2018574584258454011)  2026-02-03T06:37Z [---] followers, [---] engagements


"@EugenJen54441 @DeFiTechGlobal $DEFT's debt-free management and securing over $100 million in liquidity are expected to enable greater growth assuming cryptocurrencies like $BTC recover within two years"  
[X Link](https://x.com/shindaejin0722/status/2019568636479041933)  2026-02-06T00:27Z [---] followers, [---] engagements


"Regarding stablecoins and real-world assets (RWA) which are major streams in cryptocurrency $DEFT can invest in stablecoin companies and launch exchange-traded products (ETPs) based on RWA. My target price for $DEFT is $3 to $15"  
[X Link](https://x.com/shindaejin0722/status/2019787920794702190)  2026-02-06T14:59Z [---] followers, [---] engagements


"@CryptoYuna_ Stablecoins & RWA signify a transition to a more efficient system than the now one. This represents the most significant transformation since the shift from paper documents to digital documents & it is a social phenomenon that expands the market scale targeted by $DEFT"  
[X Link](https://x.com/shindaejin0722/status/2020466525371818227)  2026-02-08T11:55Z [---] followers, [---] engagements


"If stablecoins and real-world assets become a reality the asset value of altcoins could grow to dozens of times that of $BTC and $DEFT could grow into a 100-bagger stock"  
[X Link](https://x.com/shindaejin0722/status/2020467869184557266)  2026-02-08T12:00Z [---] followers, [---] engagements


"$DEFT As digital assets mature investors need higher-quality signals to navigate increasingly complex market dynamics. 💡 The DEFT Valour Investment Opportunity (#DVIO) Index developed by DeFi Technologies leveraging data from its regulated ETP platform @ValourFunds is an https://t.co/8KEHAqXzwZ As digital assets mature investors need higher-quality signals to navigate increasingly complex market dynamics. 💡 The DEFT Valour Investment Opportunity (#DVIO) Index developed by DeFi Technologies leveraging data from its regulated ETP platform @ValourFunds is an https://t.co/8KEHAqXzwZ"  
[X Link](https://x.com/shindaejin0722/status/2020863744612458831)  2026-02-09T14:13Z [---] followers, [---] engagements


"I understand that $DEFT will focus on marketing in [----]. Aside from @Forson's @DAF_Global activities there's nothing particularly noteworthy about $DEFT's news or management actions compared to before. @CSchlauf @jhnwtt"  
[X Link](https://x.com/shindaejin0722/status/2021220286184501374)  2026-02-10T13:50Z [---] followers, [---] engagements


"The valuation of major U.S. tech companies depends on whether their capital investments actually generate profits. $DEFT must also demonstrate the impact of hosting symposiums sponsoring various gatherings and venture investments on its bottom line. @jhnwtt @Forson @CSchlauf"  
[X Link](https://x.com/shindaejin0722/status/2021222280991248549)  2026-02-10T13:58Z [---] followers, [---] engagements


"@CSchlauf @ResourceMav @FattyFatty12352 @DeFiTechGlobal @Russ_N_Starr It seems difficult to convert everything into sales. I believe share buybacks that fail to defend the stock price are meaningless. The cryptocurrency industry must unite and respond now. The weaker the market the more essential management's efforts and marketing become. $DEFT"  
[X Link](https://x.com/shindaejin0722/status/2021342352657482231)  2026-02-10T21:55Z [---] followers, [---] engagements


"@CSchlauf @ResourceMav @FattyFatty12352 @DeFiTechGlobal @Russ_N_Starr The statement that "the institutional target price is $3.50. The stock price won't stay below $1 for long. It should be fine until two 180-day periods pass" is not the response the market expects. Management must present a concrete roadmap for the stock price to rise. $DEFT"  
[X Link](https://x.com/shindaejin0722/status/2021344253893636281)  2026-02-10T22:03Z [---] followers, [---] engagements


"$DEFT 📊 Introducing the DEFT Valour Investment Opportunity Index (DVIO) Weekly Report We are pleased to release the first edition of our weekly intelligence report tracking how institutional capital is being allocated across digital assets. The DVIO Index monitors [--] digital assets https://t.co/n7NUoWgr9P 📊 Introducing the DEFT Valour Investment Opportunity Index (DVIO) Weekly Report We are pleased to release the first edition of our weekly intelligence report tracking how institutional capital is being allocated across digital assets. The DVIO Index monitors [--] digital assets"  
[X Link](https://x.com/shindaejin0722/status/2021578549916750052)  2026-02-11T13:34Z [---] followers, [---] engagements


"I am still investing my entire investment amount in $DEFT and see the target price within the gold market as $3 to $18. It is a stock with a high risk-reward ratio"  
[X Link](https://x.com/shindaejin0722/status/2022492564734251125)  2026-02-14T02:06Z [---] followers, [---] engagements


"Duchenne muscular dystrophy (DMD) is a devastating genetic disease. A cure is not optional its essential. $SRPTs Elevidys remains the only approved treatment. Is banning it over a 0.2% risk truly what patients and families want Who is the call to cancel approval really for"  
[X Link](https://x.com/shindaejin0722/status/1935792626466443577)  2025-06-19T20:11Z [---] followers, [----] engagements


"PPMD [----] Webinar Highlights Post 1: Ingrams Personal Connection to DMD At the PPMD (June 20) Sareptas CEO Douglas Ingram shared that a family member has DMD underscoring his personal commitment to the cause. This deepens trust in $SRPTs mission to advance DMD therapies"  
[X Link](https://x.com/anyuser/status/1936147892298989613)  2025-06-20T19:43Z [---] followers, [---] engagements


"Post 2: Elevidys Patient Growth Sarepta reported Elevidys has treated [---] patients up from 900+ earlier this year. Despite safety challenges patient numbers are steadily rising showing strong demand for this DMD gene therapy. $SRPT continues to deliver. #Biotech #Elevidys"  
[X Link](https://x.com/shindaejin0722/status/1936148015947170162)  2025-06-20T19:43Z [---] followers, [---] engagements


"Post 3: Positive FDA & Expert Feedback In the webinar Ingram noted that the FDA and experts are optimistic about $SRPTs proposed adjunctive therapies (e.g. sirolimus) to address Elevidys safety issues. This could pave the way for resuming non-ambulatory patient treatments"  
[X Link](https://x.com/anyuser/status/1936148170859483388)  2025-06-20T19:44Z [---] followers, [---] engagements


"Post 4: Sareptas Transparency & Leadership Sarepta stands out in biotech for its transparency and strong management. Ingram emphasized $SRPT #SRPT"  
[X Link](https://x.com/shindaejin0722/status/1936148282222547104)  2025-06-20T19:44Z [---] followers, [----] engagements


"2/2Despite over a 50% loss I now trust $SRPT more. Their transparent communication with patient families and proactive actions set a strong example for the industry"  
[X Link](https://x.com/shindaejin0722/status/1936210940028162155)  2025-06-20T23:53Z [---] followers, [----] engagements


"4 $SRPT Even just based on this data the stock could reasonably be valued between $60 and $80. If the company resolves current issues around non-ambulatory use and achieves success with its broader pipeline a valuation north of $200 is not unrealistic"  
[X Link](https://x.com/shindaejin0722/status/1936542219403669822)  2025-06-21T21:50Z [---] followers, [----] engagements


"@douglas_ingram Please know that it's not only DMD patients who are struggling right now but also the majority of $SRPT shareholders. We are not asking for miracles we are asking for communication. We need a clear roadmap and consistent transparent updates. Rebuilding trust"  
[X Link](https://x.com/shindaejin0722/status/1937265005621314037)  2025-06-23T21:42Z [---] followers, [----] engagements


"It's been tough lately. Watching $SRPT closely. After #Elevidys expanded to non-ambulatory patients in '24 the stock fell from $170 to $19. Conservative recovery scenario: $60. Bull case: $200. All I'm focused on right now"  
[X Link](https://x.com/shindaejin0722/status/1937449493529776602)  2025-06-24T09:55Z [---] followers, [----] engagements


"$SRPT expects to present data from the Phase [--] clinical trial (EMERGENE) of SRP-9003 for LGMD Type 2E/R4 in H1 [----] . As of [--] June [----] the results have not yet been announced but are likely to be released soon as the end of H1 is near"  
[X Link](https://x.com/shindaejin0722/status/1937863876873466348)  2025-06-25T13:22Z [---] followers, [----] engagements


"Now $SRPT become a play ground of short seller. Real share holder don't sell. $srpt"  
[X Link](https://x.com/shindaejin0722/status/1937906543858786701)  2025-06-25T16:11Z [---] followers, [----] engagements


"@qxtzm54874139 This reflects the trust built between the FDA and $SRPT and may signal a strong conclusion to the Elevidys story reassuring the market of its potential and regulatory support"  
[X Link](https://x.com/shindaejin0722/status/1938151399973671067)  2025-06-26T08:24Z [---] followers, [---] engagements


"$SRPT https://biotechhealthx.com/biotech-news/sarepta-therapeutics-srpt-may-be-the-next-200-biotech-stock-wall-street-is-watching/ https://biotechhealthx.com/biotech-news/sarepta-therapeutics-srpt-may-be-the-next-200-biotech-stock-wall-street-is-watching/"  
[X Link](https://x.com/anyuser/status/1938510965089460444)  2025-06-27T08:13Z [---] followers, [---] engagements


"The reason I can't let go of $SRPT is because I believe in the company's true value the market has overreacted to the fatality and most importantly without short sellers itll bounce back to where it belongs. $SRPT"  
[X Link](https://x.com/shindaejin0722/status/1938686486611956081)  2025-06-27T19:50Z [---] followers, [----] engagements


"@mccracken_ern @obryanjf @yachmod After reading many reports it's clear that the platform technology designation is a major strength of $SRPT. It could enable [--] new drug launches per year on a consistent basis"  
[X Link](https://x.com/shindaejin0722/status/1938753934396682562)  2025-06-28T00:18Z [---] followers, [---] engagements


"🧬 $SRPT Positive Momentum Building Ahead 🧪 LGMD Phase [--] data (July) 📝 FDA immunomodulation protocol submission (July $40) 💬 FDA communication (Sept $60) possible green light for non-ambulant use 📈 Revenue recovery + BLA submission (Nov $120)"  
[X Link](https://x.com/shindaejin0722/status/1939096984721465379)  2025-06-28T23:02Z [---] followers, [----] engagements


"$SRPT https://www.facebook.com/reel/1406697437404157/mibextid=rS40aB7S9Ucbxw6v https://www.facebook.com/reel/1406697437404157/mibextid=rS40aB7S9Ucbxw6v"  
[X Link](https://x.com/shindaejin0722/status/1939536564281118770)  2025-06-30T04:08Z [---] followers, [---] engagements


"1. Mizuho's expert call indicated that the demand for walking patients is sufficient. [--]. There are approximately [----] ambulatory patients in the United States with more than [---] new cases each year. [--]. $SRPT's elevidys sales are expected to grow strongly after 3Q25"  
[X Link](https://x.com/shindaejin0722/status/1940882345512653129)  2025-07-03T21:16Z [---] followers, [---] engagements


"What I want to hear in $SRPT Q2 [----] Earnings: [--]. Strong Elevidys sales in ambulatory patients [--]. Smooth FDA discussions for non-ambulatory expansion [--]. LGMD2E EMERGENE trial success moving to pivotal [--]. Solid progress with Arrowhead collaboration"  
[X Link](https://x.com/shindaejin0722/status/1941385280159973502)  2025-07-05T06:34Z [---] followers, [----] engagements


"To all $SRPT long-position fellows: An update on LGMD2E (EmergenE) is expected at the LGMD conference (July 1820). FDA discussion progress may be shared during Q2 earnings (late Julyearly Aug). Lets stay patient and strong together"  
[X Link](https://x.com/shindaejin0722/status/1942335623312072981)  2025-07-07T21:31Z [---] followers, [---] engagements


"Mr. @douglas_ingram for $SRPT to regain trust and stabilize growth the Q2 [----] earnings call must focus on expanding #Elevidys treatment to the [---] new ambulatory DMD patients added annually in the U.S. Its time to turn potential into revenue and hope into results"  
[X Link](https://x.com/shindaejin0722/status/1942715117503930407)  2025-07-08T22:39Z [---] followers, [---] engagements


"To all $SRPT long fellows: Elevidys for ambulatory patients alone can deliver solid sustainable revenue. We must urge $SRPT and @douglas_ingram to commit fully to this path. The data and demand are therefocus is whats missing"  
[X Link](https://x.com/shindaejin0722/status/1942717204283449421)  2025-07-08T22:47Z [---] followers, [---] engagements


"$SRPT dropped from $100 to $19 not because Elevidys failed but due to a temporary halt for non-ambulatory patients. The therapy still exists and sales can shift to ambulatory use. This is not a drug failure. Its a market overreaction. $SRPT"  
[X Link](https://x.com/shindaejin0722/status/1942894588198633765)  2025-07-09T10:32Z [---] followers, [----] engagements


"$SRPT Sarepta Therapeutics Inc. (SRPT): A Bull Case Theory https://uk.finance.yahoo.com/news/sarepta-therapeutics-inc-srpt-bull-175126632.html https://uk.finance.yahoo.com/news/sarepta-therapeutics-inc-srpt-bull-175126632.html"  
[X Link](https://x.com/shindaejin0722/status/1943458916295414205)  2025-07-10T23:54Z [---] followers, [---] engagements


"To my $SRPT long fellow Almost one month passed I hope $SRPT will be turned upside by anouncing the result of LGMD2e EMERGENE tneh end of next week. I hope more than 30$"  
[X Link](https://x.com/shindaejin0722/status/1943901276829626699)  2025-07-12T05:12Z [---] followers, [----] engagements


"$SRPT 🧵 Sarepta ($SRPT) Bull Thesis July [----] 1/ $SRPT is trading near multi-year lows. Yet several underappreciated value drivers suggest a potential reversal. Here's why Sarepta may be massively undervalued.👇"  
[X Link](https://x.com/shindaejin0722/status/1944180702737838536)  2025-07-12T23:42Z [---] followers, [----] engagements


"$SRPT's Sirolimus path (as of July '25): ✅ Trial paused expert panel met ✅ Preclinical data supports Sirolimus 🔄 New protocol in dev 🔜 FDA meeting July 🔜 Filing IND/sBLA Aug 🔜 ENVISION trial restart Sep (est.)"  
[X Link](https://x.com/shindaejin0722/status/1944287861576282402)  2025-07-13T06:48Z [---] followers, [----] engagements


"✅ $SRPT remains the only player with commercial success in treating Duchenne Muscular Dystrophy (DMD). 💉 With growing evidence of long-term safety from both PMO and #Elevidys (SRP-9001) Sarepta's value proposition continues to strengthen"  
[X Link](https://x.com/shindaejin0722/status/1945085262989611069)  2025-07-15T11:37Z [---] followers, [----] engagements


"I think there are more good news to come. $SRPT"  
[X Link](https://x.com/shindaejin0722/status/1945600118797078680)  2025-07-16T21:43Z [---] followers, [---] engagements


"$SRPT is transitioning to a "Managed Bio Therapeutics Company" focusing on high-potential opportunities while mitigating high-risk ventures through collaborations and asset-sharing strategies"  
[X Link](https://x.com/shindaejin0722/status/1945774130357494089)  2025-07-17T09:14Z [---] followers, [---] engagements


"If elevidys treatment of non-ambulatory patients with sirolimus combination resumes I think $SRPT will be worth $100+ (I think the current reasonable price is $6080)"  
[X Link](https://x.com/shindaejin0722/status/1945960154610172128)  2025-07-17T21:33Z [---] followers, [----] engagements


"@yachmod It is very sad for all patients sharholder and $SRPT's employee"  
[X Link](https://x.com/shindaejin0722/status/1946347572777681108)  2025-07-18T23:13Z [---] followers, [---] engagements


"Many patients in desperate need of treatmentand investors who supported $SRPT with good intentionsare now suffering due to what I believe is poor operational judgment by the company"  
[X Link](https://x.com/shindaejin0722/status/1946515428878258228)  2025-07-19T10:20Z [---] followers, [---] engagements


"@cal89511029 A strategic buyout by a trusted name like Roche might be the only path to restoring confidence. $SRPT"  
[X Link](https://x.com/shindaejin0722/status/1946540946092417342)  2025-07-19T12:01Z [---] followers, [---] engagements


"Why not invest in US health insurance companies Medicaid and ACA are shrinking but Medicare continues to grow. Ai can help you effectively deliver value baesd care. Best of all stock prices are at new lows. $ACL"  
[X Link](https://x.com/shindaejin0722/status/1949353649697882361)  2025-07-27T06:18Z [---] followers, [--] engagements


"I believe cryptocurrency and $DEFT are poised for rapid growth. Yesterdays drop had nothing to do with $DEFT s fundamentals so I invested the last of my equity. This is just the starting line now Ill wait patiently until it reaches its full potential"  
[X Link](https://x.com/anyuser/status/1955460323789738311)  2025-08-13T02:44Z [---] followers, [---] engagements


"The business of DeFi is a tricky business that can be misinterpreted by IFRS. I'm very grateful to the folks at $DEFT for their willingness to explain.@CSchlauf @Forson @olivierfrancois"  
[X Link](https://x.com/shindaejin0722/status/1956151597085679971)  2025-08-15T00:30Z [---] followers, [---] engagements


"$DEFT's Q1 earnings were impacted by rising crypto asset values Q2 remained in the black despite declining crypto asset values Q3 saw significant AUM growth and rising crypto asset values and the company raised its full-year guidance for 2025"  
[X Link](https://x.com/anyuser/status/1956205347535810899)  2025-08-15T04:04Z [---] followers, [---] engagements


"$DEFT's Q3 results are expected to be record-breaking with revenue of $71.8 million to $86.1 million and earnings per share of $0.145 to $0.173. The cryptocurrency environment is improving and $DEFT's market and products are expanding"  
[X Link](https://x.com/anyuser/status/1957170921455939733)  2025-08-17T20:01Z [---] followers, [---] engagements


"$DEFT's proper target stock price is $8.8 $11.0. Just in my opinion"  
[X Link](https://x.com/shindaejin0722/status/1957171901786358215)  2025-08-17T20:05Z [---] followers, [---] engagements


"$DEFT's assets under management topped $10 million in early August up from $7.73 million at the end of Q2; Valuor's product count grew from [--] in Q2 to [---] by year-end; institutional investors increased from [--] to 99; and the company raised its revenue guidance to $218.5 million"  
[X Link](https://x.com/shindaejin0722/status/1957174518566285709)  2025-08-17T20:15Z [---] followers, [---] engagements


"The stock is down a bit today and it's slipping away from people's attention but the important thing is that $DEFT is doing well and the market environment couldn't be better"  
[X Link](https://x.com/shindaejin0722/status/1957562180796055820)  2025-08-18T21:56Z [---] followers, [---] engagements


"$DEFT's AUM grew to over $947M at the end of July expanded to Kenya and Turkey expanded to over [---] institutional investors expanded to over [---] valuor products and created a multi-business structure (Valour + Stillman + DeFi Alpha + Neuronomics + Reflexivity )"  
[X Link](https://x.com/anyuser/status/1957916289747546165)  2025-08-19T21:23Z [---] followers, [---] engagements


"I think it would not take too long $DEFT be big like Blackrock"  
[X Link](https://x.com/anyuser/status/1959012390693216728)  2025-08-22T21:58Z [---] followers, [---] engagements


"@rene_grnr @DeFiTechGlobal $DEFT has transformed from a penny stock into a NASDAQ-listed companystill a "baby BlackRock" but with vast potential. With seeds the market is just opening up. This is the moment for boldness. Early movers capture the advantage$DEFT is positioned to do just that"  
[X Link](https://x.com/anyuser/status/1961728368703156380)  2025-08-30T09:51Z [---] followers, [---] engagements


"I think it's better to hold $DEFT than a cryptocurrency or a company whose business is to hold cryptocurrency because $DEFT is trying to grow itself"  
[X Link](https://x.com/shindaejin0722/status/1961784772164002108)  2025-08-30T13:35Z [---] followers, [---] engagements


"@rene_grnr @Forson @CSchlauf DAT companies need to buy hold and monetize and $DEFTs can help them do so monetizing them while they hold them and liquidating them when necessary. In countries where it is not institutionalized they can also review the system and find ways to make it work"  
[X Link](https://x.com/shindaejin0722/status/1976583810453311793)  2025-10-10T09:41Z [---] followers, [--] engagements


"@CSchlauf @CheRl57 Is there no way for $DEFT to operate an ETF in the U.S. if it's not an ETP Many shareholders believe entering the U.S. market the world's financial center is absolutely necessary"  
[X Link](https://x.com/shindaejin0722/status/1996697711928918134)  2025-12-04T21:46Z [---] followers, [---] engagements


"@CSchlauf @CheRl57 Competition based on scale in beta returns such as ETP ETFs poses challenges for large financial institutions. $DEFT must solidify its own specialized position through alpha returns like DeFi alpha venture investments and consulting"  
[X Link](https://x.com/shindaejin0722/status/1996771762898673964)  2025-12-05T02:41Z [---] followers, [---] engagements


"While I don't particularly like the methods used to boost ericjackson's stock price I find his approach quite commendablecommunicating with those who share his vision even when market conditions are unfavorable reassuring them that the fundamentals remain unchanged"  
[X Link](https://x.com/shindaejin0722/status/2014062184251216311)  2026-01-21T19:46Z [---] followers, [--] engagements


"$DEFT 🔥 JUST IN: UK regulators approve Valours $BTC and $ETH physical staking ETPs for retail trading on the London Stock Exchange. https://t.co/WyfbZhzhWR 🔥 JUST IN: UK regulators approve Valours $BTC and $ETH physical staking ETPs for retail trading on the London Stock Exchange. https://t.co/WyfbZhzhWR"  
[X Link](https://x.com/shindaejin0722/status/2015830964472369495)  2026-01-26T16:55Z [---] followers, [---] engagements


"$DEFT Valour has secured UK regulatory approval and has begun offering select Valour ETPs to UK retail investors through the London Stock Exchange starting January [--] [----]. 💬 This is a major milestone for Valour and @DeFiTechGlobal as we continue expanding access to regulated https://t.co/hkU9kdiL00 Valour has secured UK regulatory approval and has begun offering select Valour ETPs to UK retail investors through the London Stock Exchange starting January [--] [----]. 💬 This is a major milestone for Valour and @DeFiTechGlobal as we continue expanding access to regulated https://t.co/hkU9kdiL00"  
[X Link](https://x.com/shindaejin0722/status/2015833515125039108)  2026-01-26T17:05Z [---] followers, [---] engagements


"$DEFT @jhnwtt @EugenJen54441 Everyone - focus needs to be on value and not putting words into Johan's mouth. Johan is Swedish. Think IKEA and Swiss army knife. Methodical smart simple and Ann executor. He walked into a bit of a rat's nest and is cleaning everything up. You have to understand how cheap this @jhnwtt @EugenJen54441 Everyone - focus needs to be on value and not putting words into Johan's mouth. Johan is Swedish. Think IKEA and Swiss army knife. Methodical smart simple and Ann executor. He walked into a bit of a rat's nest and is cleaning everything up. You have to understand how"  
[X Link](https://x.com/shindaejin0722/status/2015835535449968883)  2026-01-26T17:13Z [---] followers, [---] engagements


"Other stocks call a drop of 5% or more a sharp decline. For $DEFT a 5% or greater stock price drop is routine. Other stocks talk about growth through price increases. $DEFT talks about growth by lowering its 52-week low. Pretty unusual right @CSchlauf @jhnwtt @Forson"  
[X Link](https://x.com/shindaejin0722/status/2016609839951278208)  2026-01-28T20:30Z [---] followers, [---] engagements


"@EugenJen54441 Based on statements from $DEFT officials it appears this earnings announcement will present a concrete vision roadmap and strategy. I anticipate a more proactive vision that goes beyond merely serving as a "bridge to traditional finance."@CSchlauf @jhnwtt @Forson"  
[X Link](https://x.com/shindaejin0722/status/2016637142206992794)  2026-01-28T22:18Z [---] followers, [---] engagements


"@EugenJen54441 @CSchlauf @jhnwtt @Forson $DEFT has no plans to remain a small company or sell the business. As crypto regulations are established a vision beyond merely serving as a "bridge to traditional finance" is needed. We expect goals that reflect current trends like RWA and include concrete figures. @CSchlauf"  
[X Link](https://x.com/shindaejin0722/status/2016638249859764244)  2026-01-28T22:23Z [---] followers, [---] engagements


"$DEFT is investing in cNGN. What are we doing to make cNGN easily connected with the AI models being built We believe the future of money is AI-native. By integrating the Model Concept Protocol (MCP) were making it easy for any AI model to seamlessly interact with the cNGN protocol. Alongside this https://t.co/rL9NtHRolv What are we doing to make cNGN easily connected with the AI models being built We believe the future of money is AI-native. By integrating the Model Concept Protocol (MCP) were making it easy for any AI model to seamlessly interact with the cNGN protocol. Alongside this"  
[X Link](https://x.com/shindaejin0722/status/2016892877239177480)  2026-01-29T15:15Z [---] followers, [---] engagements


"The projects invested in by $DEFT are growing. cNGN new website is LIVE 🌐 Everything you need to understand build verify and partner cNGN all in one place. WHAT IS NEW: - Transparency Page: See reserves attestations reports and smart contract Audits - Onchain Dashboard: Track all cNGN in circulation in real-time - https://t.co/gFUT4ifdCO cNGN new website is LIVE 🌐 Everything you need to understand build verify and partner cNGN all in one place. WHAT IS NEW: - Transparency Page: See reserves attestations reports and smart contract Audits - Onchain Dashboard: Track all cNGN in circulation in"  
[X Link](https://x.com/shindaejin0722/status/2017590597415276930)  2026-01-31T13:27Z [---] followers, [---] engagements


"@Reyni985 @MissJanesMike The current price of $DEFT is abnormally low. What we know is that when $BTC was at $7800 $DEFT was trading at $2 to $3. Since then the company's fundamentals have significantly improvedturning profitable listing on Nasdaq and in Brazil and achieving [---] ETP listings"  
[X Link](https://x.com/shindaejin0722/status/2018438798452076897)  2026-02-02T21:38Z [---] followers, [--] engagements


"July [----] Started a position in Agilon Health ( $AGL) at $2.2. The stock dropped from $5 to $2 after weak Q1 results and declining members but has been forming a bottom for [--] months. Historically AGL bounced from $2 to $78 even traded at $1020 in past cycles"  
[X Link](https://x.com/shindaejin0722/status/1947427584775754051)  2025-07-21T22:44Z [---] followers, [---] engagements


"Agilon Health's May [----] Strategy: Directly Addressing Key Market Challenges Agilon Healths strategy announced in May [----] is highly relevant and well-suited to the realities revealed in Centenes Q2 [----] results. $AGL"  
[X Link](https://x.com/shindaejin0722/status/1948938046994612566)  2025-07-26T02:46Z [---] followers, [---] engagements


"In light of Centene's ($CNC) second quarter [----] results agilon health's ($AGL) strategy announced in May [----] demonstrates exceptional alignment with current market challenges. The deteriorating profitability observed at Centene"  
[X Link](https://x.com/shindaejin0722/status/1948941621283725555)  2025-07-26T03:01Z [---] followers, [---] engagements


"@CSchlauf @Forson @jhnwtt I understand that good news cannot come every day. What I want to ask is whether management recognizes that $DEFT is undervalued and is actively seeking ways to address this issue. I firmly believe management is doing so but everyone wants to hear management's position publicly"  
[X Link](https://x.com/shindaejin0722/status/2013733633547477007)  2026-01-20T22:01Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing